|
The new Commercialization Readiness Pilot (CRP) Program funding announcements have been released. These opportunities are for those with NIH SBIR or STTR Phase II or Phase IIB contract or grant awards from one of the participating NIH Institutes or Centers within the last 36 months.
-
PAR-23-219: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development - Clinical Trial Not Allowed
-
PAR-23-220: SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development - Clinical Trial Required
Key updates
- All applicants should submit a new application (Type 1) regardless of whether the Phase II award is active or has ended.
- The standard resubmission policy applies as long as applicants have a qualifying Phase II application.
- Applicants seeking technical assistance only should use PAR-23-219.
The next receipt date is Tuesday, September 5, 2023.
When the SBIR, STTR, and related pilot programs were reauthorized for FY2023-2025, the SBIR and STTR Extension Act of 2022 made several changes to the SBIR and STTR programs. Policy changes were announced June 12 through this Notice: Implementation of the NIH SBIR and STTR Foreign Disclosure Pre-award and Post-Award Requirements (NOT-OD-23-139).
Key elements include:
- disclosure requirements regarding ties to foreign countries,
- a requirement for federal agencies that manage SBIR and STTR programs to establish a due diligence program to assess security risks posed by applicants, and
- denial of award and recovery authority provisions when ties to foreign countries of concern pose a significant risk.
This policy applies to all NIH, CDC, FDA, and ACL competing applications for SBIR or STTR funding on or after September 5, 2023. More information and resources will be provided in the near future.
Recent Phase I NIH SBIR or STTR awardees (grant, contract, or Fast-Track) may request a free Technical and Business Assistance (TABA) Needs Assessment Report provided by RTI Innovation Advisors that provides an assessment of your project’s progress in four technical and business areas:
- Market Needs/Competitive Advantage
- Intellectual Property/Barriers to Entry
- Business Model Profitability
- Manufacturing, Regulatory, and/or Clinical Plan
The Needs Assessment Report helps companies strategize for their project’s next steps. There is no cost for this report and the time commitment for participation is minimal.
|
